GlobeNewswire Inc.T3·3mo ago
TBRG TruBridge, Inc. Common Stock
XNAS
26.24
Delayed
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
TBRG
$26.24
—
Key stats
$26.24
- 52-Week Range
- $13.88 – $26.51
- YTD
- +25.55%
- IV Rank (30D)
- 45.18
- Straddle Price
- $11.28
- P/C Vol Ratio
- 0.08
- Market Cap
- $0.4B
- Open
- $26.24
- Day Range
- $26.24 – $26.25
- Volume
- 302,528
- Prev Close
- $26.24
Fair Value
MODEL: SHORT
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 4.48% |
| Beta vs SPY | 1.00 |
| Cost of Equity (CAPM) | 9.98% (VRP-adj) |
| WACC | 8.40% |
| Volatility Risk Premium | +53.3pp (IV − HV30), ERP adj +50bps |
| Effective Tax Rate | 21.0% |
| Rev. Growth (YoY, DCF input) | +0.6% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.01 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.0B |
| Return on Equity (TTM) | 2.5% |
| Book / Price | 46.9% — banking bias active (P/B is primary) |
| Gross Margin (TTM) | 53.2% |
| FCF Margin (TTM) | 12.9% |
| Debt / Equity | 0.90 |
| Quality Score | 2/6 — normal (10y DCF) |
| Market-Implied Growth | -4.5% (reverse-DCF on current price) |
| SMA 50 | $25.99 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $26.16 |
| Bollinger Width / SMA20 | 4.0% (drives anchor stability) |
| Net Debt | $0.1B |
| Market Cap | $0B |
Peers used for multiples: CTSH, CYN, DOCS, EPAM, ISSC, MLGO
(SIC-code peers; ETF co-membership was sector-incoherent)
60-Day Conviction
40%
20-Day Fair Value
≈ by Aug 7, 2026
$25.23
α -3.8%
rank 75%
conviction
60%
40-Day Fair Value
≈ by Sep 7, 2026
$24.76
α -5.6%
rank 75%
conviction
60%
60-Day Fair Value
≈ by Oct 6, 2026
$24.93
α -5.0%
rank 75%
conviction
40%
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $39.03 | 23% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $4.41 | 6% | median 15.6× · 4 peers |
| Peer EV/EBITDA | $20.62 | 7% | median 9.9× · 4 peers |
| Peer P/B | $16.85 | 9% | median 1.4× · 6 peers |
| Peer P/S | $72.85 | 9% | median 3.0× · 6 peers |
| Market Anchor (SMA50) | $25.99 | 46% | stability 100% (BB-width) |
| Options Expected (B-L 30d) | n/a | 0% |
As of 2026-07-09 · updated
Related
About
- Industry (SIC)
- SERVICES-COMPUTER PROGRAMMING SERVICES (7371) · industry map
- Exchange
- XNAS
- Market Cap
- $0.4B
- Employees
- 3,500
- List Date
- 2002-05-21
- CIK
- 0001169445
- Headquarters
- Mobile, AL
- Homepage
- https://www.trubridge.com
TruBridge Inc is a provider of healthcare solutions and services for community hospitals, clinics, and other healthcare systems. It provides services such as Electronic health records & information systems, revenue cycle management, population health, and data management, etc. The Company operates its business in two operating segments, which are: Financial Health and Patient Care. The Financial Health segment generating key revenue focuses on providing business management, consulting, and managed IT services, along with a complete RCM solution for all care settings, regardless of their primar…
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
Insufficient price history — listed 8920 days ago. Seasonality patterns need at least one full year of data.
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $26.16
SMA 50: $25.99
SMA 200: $21.62
Current: $26.24
EMA 12: $26.20
EMA 26: $26.01
MACD: 0.1874 | Signal: -0.0517
BULLISH
ADX (14): 72.35
STRONG TREND
+DI: 37.42
−DI: 7.03
Momentum Oscillators
RSI (14): 79.10
OVERBOUGHT
Stoch %K: 95.83
Stoch %D: 97.92
Williams %R: -6.25
Volume & Volatility
BB Upper: $26.29
BB Lower: $26.02
NEUTRAL
OBV: 11,405,340
Vol SMA 20: 301,239
Vol ROC: 7.18%
ATR: $0.07
True Range: $0.01
HV 20: 1.6%
HV 30: 1.6%
HV 60: 42.8%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-07-10T00:00:00 – 2026-07-08T00:00:00
AI Analysis
LLM Stock Analysis Report: TBRG
Executive Summary
Overall assessment: BEARISH with confidence level (6/10)
Key drivers and primary risks:
- Recent negative news sentiment impacting stock price
- Strong technical signals indicating overbought conditions
- High volatility regime, potentially leading to increased risk
Investment thesis: TBRG's recent decline can be attributed to the negative news headlines, which have led to a shift in investor sentiment. While the company has shown resilience in the past, the current technical and market conditions suggest a higher probability of further declines.
Recent news sentiment impact: Negative news headlines have significantly impacted TBRG's stock price, leading to a bearish bias.
Technical Analysis
Trend Direction: Short-term (1-4 weeks): BEARISH, Medium-term (1-3 months): NEUTRAL, Long-term (3-12 months): BULLISH
Support/Resistance Levels:
- Lower band: $25.70
- Middle band: $25.86
- Upper band: $26.02
Momentum Signals:
- RSI interpretation: Overbought (>70)
- MACD signal: Bullish momentum (0.90 / Signal: -0.27 / Histogram: 1.16)
- Bollinger Bands position: Neutral (squeeze)
Volume Analysis: Volume trends and institutional interest signals:
- On-Balance Volume (OBV): 7593017.01
- Volume Rate of Change: 50.19%
News & Sentiment Analysis
Recent Headlines Summary: Key themes from last 10 news articles:
- All recent headlines are negative, indicating a bearish sentiment.
Sentiment Assessment: Aggregate news sentiment (negative)
Catalyst Identification: Upcoming events, earnings, product launches, regulatory changes:
- No specific catalysts identified
Risk & Volatility Assessment
Beta Interpretation: Risk relative to market (beta 0.85 vs SPY): Moderate risk
Volatility Regime: Current volatility regime: High (Historical Volatility: HV20 2.4%, HV30 37.2%, HV60 57.0%)
Options Market Signals:
- IV Rank: 75.8% (High)
- Current IV: 228.4%
- Expected Move: $1.23 (21 DTE), 7-DTE: $1.23
Market Context & Positioning
Sector Performance: Relative strength vs sector/market:
- Weak performance in the sector, with TBRG underperforming the market.
Institutional Activity: Volume patterns suggesting institutional interest:
- No specific institutional activity detected
Correlation Analysis: How stock moves relative to market (R-squared interpretation):
- Moderate correlation (0.24) suggests some market influence, but not a strong indicator of future price movements.
Key Levels & Action Items
Critical Price Levels:
- Support: $25.70
- Resistance: $26.02
Breakout/Breakdown Levels:
- Breakout above $26.02 could lead to further gains.
- Breakdown below $25.70 could accelerate declines.
Time-Sensitive Catalysts: Earnings dates, FDA approvals, product launches:
- No specific catalysts identified
Risk Management: Stop-loss levels and position sizing considerations:
- Consider setting stop-loss at $24.90 (just above the lower band) to limit potential losses.
- Adjust position size accordingly based on risk tolerance.
By analyzing the data, I conclude that TBRG is in a bearish trend, with strong technical signals indicating overbought conditions. The recent negative news sentiment has further exacerbated the decline, and volatility remains high. While there are some bullish signals in the long-term indicators, the current market conditions suggest a higher probability of further declines.
Generated
News
All TBRG news →
GlobeNewswire Inc.T3·3mo ago
GlobeNewswire Inc.T3·4mo ago
GlobeNewswire Inc.T3·4mo ago
GlobeNewswire Inc.T3·4mo ago
GlobeNewswire Inc.T3·4mo ago
GlobeNewswire Inc.T3·4mo ago
GlobeNewswire Inc.T3·4mo ago
GlobeNewswire Inc.T3·4mo ago
GlobeNewswire Inc.T3·4mo ago
Showing 1–10 of 33
Page 1 of 4
Earnings History
8 of 8 under expected move
Avg Expected Move
20.14%
Avg Actual Move
4.05%
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2024-05-10 | After-Close | 14.60% | 1.03% | 0.07x | Within |
| 2024-08-08 | After-Close | 33.17% | 24.46% | 0.74x | Within |
| 2024-11-07 | After-Close | 11.61% | 0.15% | 0.01x | Within |
| 2025-03-18 | After-Close | 7.06% | 2.97% | 0.42x | Within |
| 2025-05-07 | After-Close | 11.67% | 1.96% | 0.17x | Within |
| 2025-08-08 | After-Close | 25.38% | 1.48% | 0.06x | Within |
| 2025-11-06 | Pre-Market | 25.40% | 0.26% | 0.01x | Within |
| 2026-05-06 | Pre-Market | 32.23% | 0.08% | 0.00x | Within |
Earnings calendar: this week’s reports with expected vs actual moves →
TBRG Options Activity & IV Rank
TBRG IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Current IV: 67.3%
7-DTE IV: —
Expected Move: $11.28
7-DTE Move: $1.15
Days to Exp: 44 (2026-08-21)
Options Flow
Call Volume: 201
Put Volume: 16
P/C Volume: 0.08
BULLISH
Call OI: 440
Put OI: 16
P/C OI: 0.036
Total OI: 456
ATM Options Pricing
ATM Call: $1.27
ATM Put: $10.00
Call %: 4.9%
Put %: 38.1%
Chain Summary
Chain Volume: 2,160
Chain OI: 9,126
Last Updated: 7/8/2026
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Dealer Positioning
HIGH γ vs HISTORY
Estimated net dealer gamma is at the 98th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.
Gamma percentile
98%
vs own history
GEX tilt
+0.98
OI-weighted, today
Vanna tilt
-0.92
δ-sensitivity to IV
Charm tilt
+0.89
δ-decay vs time
Vanna tilt -0.92: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt +0.89: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably as time passes and options approach expiry.
? What is this?
· 7 ATM contracts, 8k total OI
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
as of Jul 8 · No data
30 DTE / 10d
—
—
pts
EXTREME
as of Jul 8 · No data
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)45.2MediumJul 8
Straddle Price (30 DTE)$11.28Jul 8
Beta Analysis
Insufficient price history — listed 8920 days ago. Beta and correlation vs SPY require ~1 year of daily returns to be statistically meaningful.
Notable investors who own TBRG
3 of 37 tracked investors
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Millennium Management Hedge fund Izzy Englander | $3.7M | #2245 of 3716 | +820.0% | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $1.6M | #2084 of 3138 | new | 13F | |
| Citadel Hedge fund Ken Griffin | $391K | #4765 of 6285 | +0.9% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
TBRG Institutional Ownership (13F)
Latest filings — 2026-06-30
? 13F Guide
Diluted shares outstanding: 14,525,500 (as of 2026-03-31)
Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
3 filers$5.87M notional
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Susquehanna International Group, LLP Custodian | $4.64M | 78.94% | 2026-06-30 |
| 2 | Jane Street Group, LLC Custodian | $767.95K | 13.07% | 2026-06-30 |
| 3 | Citadel Advisors LLC Custodian | $469.16K | 7.99% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|
TBRG Insider Trading (Form 4)
Latest: 2026-07-10Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-07-10 | Regina M. Benjamin | Director | Disp (D) | −38,687 | $26.25 | -$1.02M | EDGAR |
| 2026-07-10 | L6 Holdings Inc. | 10%+ Owner | U | −5,960,000 | $26.25 | -$156.45M | EDGAR |
| 2026-07-10 | Mark V Anquillare | Director | Disp (D) | −21,554 | $26.25 | -$565.8K | EDGAR |
| 2026-07-10 | David A Dye | Director | Mixed | −130,436 | $26.32 | -$3.43M | EDGAR |
| 2026-07-10 | Christopher T Hjelm | Director | Disp (D) | −31,591 | $26.25 | -$829.3K | EDGAR |
| 2026-07-10 | Damien Leonard | Director | Disp (D) | −2,980,000 | $26.25 | -$78.22M | EDGAR |
| 2026-07-10 | Christopher L Fowler | President and CEO | Disp (D) | −136,788 | $26.25 | -$3.16M | EDGAR |
| 2026-07-10 | Kevin Plessner | General Counsel | Disp (D) | −14,610 | $26.25 | -$327.1K | EDGAR |
| 2026-07-10 | Andris Upitis | Director | Disp (D) | −1,118,554 | $26.25 | -$29.36M | EDGAR |
| 2026-07-10 | David Harse | General Manager Patient Care | Disp (D) | −21,091 | $26.25 | -$443.3K | EDGAR |
| 2026-07-10 | Vita MacIntyre | Controller | Disp (D) | −2,687 | $26.25 | -$50.8K | EDGAR |
| 2026-07-10 | Glenn Tobin | Director | Disp (D) | −50,687 | $26.25 | -$1.33M | EDGAR |
| 2026-07-10 | Michael Daughton | Chief Business Officer | Disp (D) | −68,064 | $26.25 | -$1.56M | EDGAR |
| 2026-07-10 | Vinay Bassi | Chief Financial Officer | Disp (D) | −50,499 | $26.25 | -$1.05M | EDGAR |
| 2026-07-10 | Merideth Wilson | Financial Health GM | Disp (D) | −12,042 | $26.25 | -$203.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
TBRG Insider Holdings
8 insiders · @ $26.24
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Pinetree Capital Ltd. | 10%+ Owner | 2,075,000 | $54.45M | $27.83M | 9 | 2025-12-03 |
| 2 | Christopher L Fowler | President and CEO | 120,486 | $3.16M | -$287.9K | 13 | 2026-07-10 |
| 3 | David A Dye | Chief Operating Officer | 81,646 | $2.14M | $0 | 6 | 2026-07-10 |
| 4 | Michael Daughton | Chief Business Officer | 59,315 | $1.56M | $999.2K | 4 | 2026-07-10 |
| 5 | Vinay Bassi | Chief Financial Officer | 39,992 | $1.05M | $0 | 6 | 2026-07-10 |
| 6 | Dawn M Severance | Chief Sales Officer | 30,595 | $802.8K | $0 | 5 | 2025-03-18 |
| 7 | David Harse | General Manager Patient Care | 16,888 | $443.1K | -$47.8K | 7 | 2026-07-10 |
| 8 | Kevin Plessner | General Counsel | 12,460 | $327.0K | $0 | 9 | 2026-07-10 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
TBRG Board & Officers
As of SEC filings through Jul 10, 2026Changes in the last 10 years (62)
| Jul 10, 2026 | Vita MacIntyre reported in an SEC filing no longer being Controller |
| Jul 10, 2026 | Vinay Bassi reported in an SEC filing no longer being Chief Financial Officer |
| Jul 10, 2026 | Regina M. Benjamin reported in an SEC filing no longer being a director |
| Jul 10, 2026 | Pinetree Capital Ltd. reported in an SEC filing no longer being a 10% owner |
| Jul 10, 2026 | Michael Daughton reported in an SEC filing no longer being Chief Business Officer |
| Jul 10, 2026 | Merideth Wilson reported in an SEC filing no longer being Financial Health GM |
| Jul 10, 2026 | Mark V Anquillare reported in an SEC filing no longer being a director |
| Jul 10, 2026 | L6 Holdings Inc. reported in an SEC filing no longer being a 10% owner |
| Jul 10, 2026 | Kevin Plessner reported in an SEC filing no longer being General Counsel |
| Jul 10, 2026 | Jerry G Canada Jr. reported in an SEC filing no longer being a director |
| Jul 10, 2026 | Glenn Tobin reported in an SEC filing no longer being a director |
| Jul 10, 2026 | David Harse reported in an SEC filing no longer being General Manager Patient Care |
| Jul 10, 2026 | David A Dye reported in an SEC filing no longer being a director |
| Jul 10, 2026 | Damien Leonard reported in an SEC filing no longer being a director |
| Jul 10, 2026 | Christopher T Hjelm reported in an SEC filing no longer being a director |
| Jul 10, 2026 | Christopher L Fowler reported in an SEC filing no longer being a director |
| Jul 10, 2026 | Christopher L Fowler reported in an SEC filing no longer being President and CEO |
| Jul 10, 2026 | Andris Upitis reported in an SEC filing no longer being a director |
| Jul 10, 2026 | Amy K O'Keefe reported in an SEC filing no longer being a director |
| Jan 12, 2026 | Damien Leonard became a director |
| Oct 6, 2025 | Michael Daughton became Chief Business Officer |
| Feb 11, 2025 | Jerry G Canada Jr. became a director |
| Feb 11, 2025 | Andris Upitis became a director |
| Feb 4, 2025 | Merideth Wilson became Financial Health GM |
| Feb 4, 2025 | David Harse became General Manager Patient Care |
| Nov 1, 2024 | The company announced the departure of David A Dye as Chief Operating Officer in an SEC filing |
| Oct 18, 2024 | The company announced the departure of Denise Wilder Warren from the board in an SEC filing |
| Oct 18, 2024 | Amy K O'Keefe became a director |
| Mar 27, 2024 | Vita MacIntyre became Controller |
| Mar 19, 2024 | Dawn M Severance listed as Chief Sales Officer (previously SVP of TruBridge, Sales) in SEC filings |
| Mar 11, 2024 | Pinetree Capital Ltd. became a 10% owner |
| Mar 11, 2024 | L6 Holdings Inc. became a 10% owner |
| Feb 5, 2024 | The company announced the departure of Charles P Huffman from the board in an SEC filing |
| Jan 1, 2024 | Vinay Bassi became Chief Financial Officer |
| Nov 1, 2023 | The company announced the departure of Matt J Chambless as CFO, Secretary & Treasurer in an SEC filing |
| Jul 28, 2023 | Mark V Anquillare became a director |
| Mar 17, 2023 | Lance Park became VP Finance & Controller |
| Feb 8, 2023 | Wes Cronkite became Chief Technology & Innovation |
| Feb 8, 2023 | Kevin Plessner became General Counsel |
| Nov 16, 2022 | John B Douglas Jr reported in an SEC filing no longer being a director |
| Nov 16, 2022 | John B Douglas Jr reported in an SEC filing no longer being President and CEO |
| Nov 2, 2022 | David A Dye listed as Chief Operating Officer (previously Chief Growth Officer) in SEC filings |
| Oct 28, 2022 | The company announced the departure of James B Britain as VP - Finance and Controller in an SEC filing |
| Oct 7, 2022 | The company announced the departure of Troy D Rosser as Senior Vice President - Sales in an SEC filing |
| Jul 6, 2022 | Christopher L Fowler listed as President and CEO (previously COO and President (TruBridge)) in SEC filings |
| Jul 6, 2022 | Christopher L Fowler first listed as a director in an SEC filing |
| Feb 2, 2022 | James Patrick Murphy became SVP, TruBridge, Bus. Service |
| Feb 2, 2022 | Dawn M Severance became SVP of TruBridge, Sales |
| Feb 2, 2022 | Claire Stephens became SVP, Post Acute Care |
| Feb 2, 2022 | Amaris Angelica McComas became Chief People Officer |
| Dec 27, 2019 | Christopher T Hjelm became a director |
| Feb 27, 2019 | Jeffrey A. Strong became a director |
| Nov 16, 2018 | Francisco Partners Parallel Fund II, L.P. reported in an SEC filing no longer being a 10% owner |
| Nov 16, 2018 | Francisco Partners II, LP reported in an SEC filing no longer being a 10% owner |
| Nov 16, 2018 | Francisco Partners GP II, LP reported in an SEC filing no longer being a 10% owner |
| Nov 16, 2018 | Francisco Partners GP II Management, LLC reported in an SEC filing no longer being a 10% owner |
| Mar 8, 2018 | Robert D Hinckle listed as Senior VP - Client Services (previously Senior VP - Software Services) in SEC filings |
| Jan 19, 2018 | Robert D Hinckle listed as Senior VP - Software Services (previously Senior VP - Client Services) in SEC filings |
| Nov 30, 2017 | Christopher L Fowler no longer listed as a director in SEC filings |
| Nov 9, 2017 | Regina M. Benjamin became a director |
| Nov 9, 2017 | Glenn Tobin became a director |
| Nov 9, 2017 | Denise Wilder Warren became a director |
Not reported recently (13)
- Dawn M Severance · Last reported as Chief Sales Officer in an SEC filing dated Mar 18, 2025
- Wes Cronkite · Last reported as Chief Technology & Innovation in an SEC filing dated Mar 19, 2024
- Lance Park · Last reported as VP Finance & Controller in an SEC filing dated Mar 19, 2024
- Robert D Hinckle · Last reported as Senior VP - Client Services in an SEC filing dated Aug 17, 2022
- Amaris Angelica McComas · Last reported as Chief People Officer in an SEC filing dated May 5, 2022
- James Patrick Murphy · Last reported as SVP, TruBridge, Bus. Service in an SEC filing dated Mar 11, 2022
- Claire Stephens · Last reported as SVP, Post Acute Care in an SEC filing dated Mar 10, 2022
- Victor S Schneider · Last reported as Executive Vice President in an SEC filing dated Nov 12, 2020
- Jeffrey A. Strong · Last reported as a director in an SEC filing dated Oct 19, 2020
- William A Mulherin III · Last reported as a director in an SEC filing dated Mar 9, 2020
- Arthur Robert Outlaw Jr · Last reported as a director in an SEC filing dated Mar 11, 2019
- John Charles Johnson · Last reported as a director in an SEC filing dated Mar 8, 2018
- William R Seifert II · Last reported as a director in an SEC filing dated May 12, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
TBRG Proposed Insider Sales (Form 144)
Latest: 2025-05-20
? Form 144 Guide
Last 30d:
0 filings
· Last 90d:
0 filings
What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2025-05-20 | MacIntyre Vita | Officer | 335 | $8.4K | 2025-05-20 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-05-16 | Fowler Christopher L | Officer, Director | 6,000 | $150.3K | 2025-05-16 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-03-14 | Cronkite Wes | Officer | 15,000 | $403.4K | 2025-03-14 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-03-14 | Harse David | Officer | 1,744 | $47.8K | 2025-03-14 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-03-13 | Fowler Christopher L | Officer, Director | 5,100 | $141.6K | 2025-03-13 | Charles Schwab Corp | — | EDGAR |
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
ETF Holders
9 ETFs hold TBRG
9 shown · $2.41M total exposure
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | SCHA Schwab U.S. Small-Cap ETF | Nport | 0.01% | $1.2M | — | 2026-05-31 |
| 2 | ARB AltShares Merger Arbitrage ETF | Nport | 0.55% | $568,394 | — | 2026-05-31 |
| 3 | EES WisdomTree U.S. SmallCap Fund | Nport | 0.04% | $314,887 | — | 2026-06-30 |
| 4 | SCHB Schwab U.S. Broad Market ETF | Nport | 0.00% | $216,714 | — | 2026-05-31 |
| 5 | FSCC Federated Hermes MDT Small Cap Core ETF | Nport | 0.02% | $56,463 | — | 2026-05-31 |
| 6 | OMFS Invesco Russell 2000 Dynamic Multifactor ETF | Nport | 0.01% | $22,118 | — | 2026-05-31 |
| 7 | LGHT Langar Global Health Tech ETF | Nport | 0.04% | $1,048 | — | 2026-06-30 |
| 8 | RESM Columbia Research Enhanced Small Cap ETF | Nport | 0.02% | $603 | — | 2026-06-30 |
| 9 | EBI Longview Advantage ETF | Nport | 0.00% | $363 | — | 2026-05-31 |
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Trailing P/E
—
TTM Diluted EPS
$0.28
TTM Revenue
$345.90M
TTM Net Income
$4.37M
TTM Op. Cash Flow
$46.66M
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q1 '26 | 2026-03-31 | $86.27M | $506.00K | $0.03 | $15.45M |
| Q4 '25 | 2025-12-31 | $87.79M | $-4.14M | $-0.29 | $8.86M |
| Q3 '25 | 2025-09-30 | $86.11M | $5.42M | $0.37 | $13.59M |
| Q2 '25 | 2025-06-30 | $85.73M | $2.58M | $0.17 | $8.76M |
| Q1 '25 | 2025-03-31 | $87.21M | $459.00K | $0.03 | $5.76M |
| Q4 '24 | 2024-12-31 | $87.79M | $-5.34M | $-0.37 | $9.30M |
| Q3 '24 | 2024-09-30 | $84.70M | $-8.78M | $-0.61 | $10.11M |
| Q2 '24 | 2024-06-30 | $85.60M | $-4.39M | $-0.29 | $13.76M |
| Q1 '24 | 2024-03-31 | $84.12M | $-1.85M | $-0.13 | $-2.03M |
| Q2 '19 | 2019-06-30 | $21.69M | $4.16M | $4156093.00 | — |
| Q1 '19 | 2019-03-31 | $23.02M | $4.86M | $4864.39 | $-343.01K |
| Q4 '18 | 2018-12-31 | $33.86M | $2.15M | $2145.68 | $10.48M |
Q1 2026 • period ending 2026-03-31 • filed 2026-05-08
Valuation
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
Price Multiples
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
P/E
0.00
P/B
—
P/S
—
EV/EBITDA
—
EV/Sales
—
ROE
2.4%
ROA
1.1%
Div Yield
0.00%
FCF Yield
—
Debt/Equity
0.90
Current Ratio
—
Market Cap
$0.00
as of 2026-07-09
Short Interest & Float
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
Metric definitions
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.
Short Interest
548.56K
SI % of Float
5.85%
Days to Cover
1.89
Short Vol Ratio
93.1%
Free Float
9.38M
Float %
62.5%
Short interest 2026-06-30 • Short volume 2026-07-08 • Float 2026-05-13